Wyeth Loratadine Exclusivity Should Reflect Alavert Approval Date – Andrx
This article was originally published in The Tan Sheet
Executive Summary
Marketing exclusivity for Wyeth Consumer Healthcare's generic loratadine tablets should begin on "the date on which Wyeth began marketing generic loratadine in its product Alavert," rival marketer Andrx asserts in a Feb. 27 citizen petition